Comparison of several prognostic tools in traumatic brain injury including S100B

Brain Injury

Volumn 28, Issue 7, 2014, Pages 987-994

  Lesko, Mehdi Moazzez ^a   O'Brien, Sarah J ^b   Childs, Charmaine ^c   Bouamra, Omar ^a   Rainey, Timothy ^d   Lecky, Fiona ^a,e  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Outcome; Prognosis; Prognostic models; S100B; Traumatic brain injury

Indexed keywords

PROTEIN S100B; BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PREDICTION; PROGNOSIS; PROGNOSTIC MODEL B; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL PREDICTION; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; COMPARATIVE STUDY; DISEASE COURSE; GLASGOW COMA SCALE; INJURY SCALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; THEORETICAL MODEL;

BIOLOGICAL MARKERS; BRAIN INJURIES; DISEASE PROGRESSION; FEMALE; GLASGOW COMA SCALE; HUMANS; INJURY SEVERITY SCORE; MALE; MODELS, THEORETICAL; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; S100 PROTEINS;

EID: 84900801111     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2014.890743     Document Type: Article

References (63)

1. Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, et al. Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Medicine 2008;5:e 165; discussion e165.
2. Walder AD, Yeoman PM, Turnbull A. The abbreviated injury scale as a predictor of outcome of severe head injury. Intensive Care Medicine 1995;21: 606-609.
3. Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. Predicting outcome after traumatic brain injury: Practical prognostic models based on large cohort of international patients. British Medical Journal (Clinical Research Edition) 2008;336: 425-429.
4. The Trauma Audit and Research Network. Manchester, UK: The Trauma Audit and Research Network (TARN). Available online at: http://www.tarn.ac.uk/, accessed 17 February 2012.
5. Lesko MM, Jenks T, Perel P, O'Brien S, Childs C, Bouamra O, Lecky F. Models of mortality probability in severe traumatic brain injury: Results of the modelling by the UK Trauma Registry. Journal of Neurotrauma 2013;30(12): 2778-2779.
6. Qureshi AI. Evaluation of brain injury using a blood test: Is there a role in clinical practice? Critical Care Medicine 2002;30: 2778-2779.
7. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. International Journal of Biochemistry & Cell Biology 2001;33: 637-668.
8. Stalnacke BM, Bjornstig U, Karlsson K, Sojka P. One-year followup of mild traumatic brain injury: Post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S- 100B and neurone-specific enolase in acute phase. Journal of Rehabilitation Medicine 2005;37: 300-305.
9. Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. European Journal of Neurology 2003;10: 175-181.
10. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: A role for protein S-100B? Journal of Neurology, Neurosurgery & Psychiatry 2002; 73: 542-546.
11. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62: 1303-1310.
12. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24 h) time-point. Resuscitation 2009;80: 341-345.
13. Chatfield DA, Zemlan FP, Day DJ, Menon DK. Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: A pilot study. British Journal of Neurosurgery 2002;16: 471-476.
14. Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner- Steppert C, Mutschler W, Jochum M. Serum S-100B and interleukin- 8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Critical Care Medicine 2002;30: 2669-2674.
15. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE, Roussos C. Protein S-100b serum levels in traumainduced brain death. Neurology 2003;60: 947-951.
16. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of Neurology, Neurosurgery & Psychiatry 2001;70: 95-100.
17. Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M. S-100beta proteinserum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Critical Care Medicine 2003;31: 939-945.
18. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S- 100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999;45: 468-475; discussion 475-466.
19. Mercier E, Boutin A, Lauzier F, Fergusson DA, Simard JF, Zarychanski R, Moore L, McIntyre LA, Archambault P, Lamontagne F, et al. Predictive value of S-100beta protein for prognosis in patients with moderate and severe traumatic brain injury: Systematic review and meta-analysis. British Medical Journal (Clinical Research Edition) 2013;346:f1757.
20. Gradisek P, Osredkar J, Korsic M, Kremzar B. Multiple indicators model of long-term mortality in traumatic brain injury. Brain Injury 2012;26: 1472-1481.
21. Goyal A, Failla MD, Niyonkuru C, Amin K, Fabio A, Berger RP, Wagner AK. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. Journal of Neurotrauma 2013;30: 946-957.
22. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. The Journal of Trauma 1999;47: 1126-1130.
23. Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S 100 B: A marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003;19: 195-200.
24. Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG, for the PG. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research. PLoS Medicine 2013;10:e1001381.
25. Riley RD, Hayden JA, Steyerberg EW, Moons KGM, Abrams K, Kyzas PA, Malats N, Briggs A, Schroter S, Altman DG, et al. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research. PLoS Medicine 2013;10:e1001380.
26. Raj R, Siironen J, Kivisaari R, Hernesniemi J, Tanskanen P, Handolin L, Skrifvars MB. External validation of the international mission for prognosis and analysis of clinical trials model and the role of markers of coagulation. Neurosurgery 2013;73: 305-311.
27. Lingsma H, Andriessen TM, Haitsema I, Horn J, van der Naalt J, Franschman G, Maas AI, Vos PE, Steyerberg EW. Prognosis in moderate and severe traumatic brain injury: External validation of the IMPACT models and the role of extracranial injuries. The Journal of Trauma and Acute Care Surgery 2013;74: 639-646.
28. Panczykowski DM, Puccio AM, Scruggs BJ, Bauer JS, Hricik AJ, Beers SR, Okonkwo DO. Prospective independent validation of IMPACT modeling as a prognostic tool in severe traumatic brain injury. Journal of Neurotrauma 2012;29: 47-52.
29. Roozenbeek B, Lingsma HF, Lecky FE, Lu J, Weir J, Butcher I, McHugh GS, Murray GD, Perel P, Maas AI, et al. Prediction of outcome after moderate and severe traumatic brain injury: External validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic models. Critical Care Medicine 2012;40: 1609-1617.
30. Roozenbeek B, Chiu YL, Lingsma HF, Gerber LM, Steyerberg EW, Ghajar J, Maas AI. Predicting 14-day mortality after severe traumatic brain injury: Application of the IMPACT models in the brain trauma foundation TBI-trac(R) New York State database. Journal of Neurotrauma 2012;29: 1306-1312.
31. Maas AI, Steyerberg EW, Marmarou A, McHugh GS, Lingsma HF, Butcher I, Lu J, Weir J, Roozenbeek B, Murray GD. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics: The Jjournal of the American Society for Experimental NeuroTherapeutics 2010;7: 127-134.
32. Turner EL, Perel P, Clayton T, Edwards P, Hernandez AV, Roberts I, Shakur H, Steyerberg EW. Covariate adjustment increased power in randomized controlled trials: An example in traumatic brain injury. Journal of Clinical Epidemiology 2012;65: 474-481.
33. Lingsma H, Roozenbeek B, Steyerberg E. Covariate adjustment increases statistical power in randomized controlled trials. Journal of Clinical Epidemiology 2010;63: 1391; author reply 1392-1393.
34. Weir J, Steyerberg EW, Butcher I, Lu J, Lingsma HF, McHugh GS, Roozenbeek B, Maas AI, Murray GD. Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale? Journal of Neurotrauma 2012;29: 53-58.
35. Lingsma HF, Roozenbeek B, Perel P, Roberts I, Maas AI, Steyerberg EW. Between-centre differences and treatment effects in randomized controlled trials: A case study in traumatic brain injury. Trials 2011;12: 201.
36. Rodriguez-Rodriguez A, Egea-Guerrero JJ, Leon-Justel A, Gordillo-Escobar E, Revuelto-Rey J, Vilches-Arenas A, Carrillo- Vico A, Dominguez-Roldan JM, Murillo-Cabezas F, Guerrero JM. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults. Clinica Chimica Acta; International Journal of Clinical Chemistry 2012; 414: 228-233.
37. Niyonkuru C, Wagner AK, Ozawa H, Amin K, Goyal A, Fabio A. Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: A practical example. Journal of Neurotrauma 2013;30: 938-945.
38. Thelin EP, Johannesson LK, Nelson DW, Bellander BM. S100B is an important outcome predictor in traumatic brain injury. Journal of Neurotrauma 2013;11(1): 9-7.
39. Swets JA, Getty DJ, Pickett RM, D'Orsi CJ, Seltzer SE, McNeil BJ. Enhancing and evaluating diagnostic accuracy. Medical Decision Making 1991;11: 9-17.
40. Cancer Detection Section, Breast Expert Workshop. Early and locally advanced breast cancer: Diagnosis and treatment. United Kingdom: National Institue for Health and Clinical Excellence; 2009. p 12.
41. Workshop BE. Breast cancer diagnostic algorithms for primary care providers. In: Section C, editor. The United States of America: California Department of Public Health; 2011. p 5.
42. Nylen K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, Nellgard B, Rosengren L. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochirurgica 2008;150: 221-227; discussion 227.
43. Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AI, Marmarou A, Steyerberg EW. Multivariable prognostic analysis in traumatic brain injury: Results from the IMPACT study. Journal of Neurotrauma 2007;24: 329-337.
44. Maas AI, Steyerberg EW, Butcher I, Dammers R, Lu J, Marmarou A, Mushkudiani NA, McHugh GS, Murray GD. Prognostic value of computerized tomography scan characteristics in traumatic brain injury: Results from the IMPACT study. Journal of Neurotrauma 2007;24: 303-314.
45. Butcher I, Maas AI, Lu J, Marmarou A, Murray GD, Mushkudiani NA, McHugh GS, Steyerberg EW. Prognostic value of admission blood pressure in traumatic brain injury: Results from the IMPACT study. Journal of Neurotrauma 2007;24: 294-302.
46. McHugh GS, Engel DC, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Hernandez AV, Marmarou A, Maas AI, Murray GD. Prognostic value of secondary insults in traumatic brain injury: Results from the IMPACT study. Journal of Neurotrauma 2007;24: 287-293.
47. Van Beek JG, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, Lu J, Marmarou A, Murray GD, Maas AI. Prognostic value of admission laboratory parameters in traumatic brain injury: Results from the IMPACT study. Journal of Neurotrauma 2007;24: 315-328.
48. David W, Hosmer SL. Applied logistic regression. 2nd ed. The United States of America: Wiley-Interscience Publication; 2000.
49. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Interntional Journal of Epidemiology 1999;28: 964-974.
50. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991;78: 691-692.
51. McMorran J, Crowther DC, McMorran S, Prince C, YoungMin S, Pleat J. General Practice Notebook- A UK medical reference on the world wide web. Anemia, UK: Oxbridge Solutions Ltd. Available online at: http://gpnotebook.com/ simplepage.cfm?ID= 1436155983, accessed 17 February 2012.
52. McMorran J, Crowther DC, McMorran S, Prince C, YoungMin S, Pleat J. General Practice Notebook- A UK medical reference on the word wide web. Hyperglycemia, UK: Oxbridge Solutions Ltd. Available online at: http://www.gpnotebook.co.uk/simplepage. cfm?ID=899285013, accessed 17 February 2012.
53. McMorran J, Crowther DC, McMorran S, Prince C, YoungMin S, Pleat J. General Practice Notebook- A UK medical reference on the word wide web. Hypoglycemia, UK: Oxbridge Solutions Ltd. Available online at: http://www.gpnotebook.co.uk/simplepage.cfm? ID=x20090122054239749131, accessed 17 February 2012.
54. Marshall LF, Marshall SB, Klauber MR, Clark MvB, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Special Supplements 1991;75(Suppl 1):S14-S20.
55. Olivecrona M, Rodling-Wahlstrom M, Naredi S, Koskinen LO. S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy. Journal of Neurology, Neurosurgery & Psychiatry 2009;80: 1241-1247.
56. Bechtel K, Frasure S, Marshall C, Dziura J, Simpson C. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics 2009;124:e697-704.
57. Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G, Pirozzi N, Tufano R. S100B is not a reliable prognostic index in paediatric TBI. Pediatric Neurosurgery 2007;43: 258-264.
58. Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Injury 2006;20: 759-765.
59. Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78: 1428-1433.
60. Homolkova H, Prchlik M, Tomek P. The relationship between S100B protein serum levels, injury severity and Glasgow Outcome Scale values in children with CNS injuries. Neuro Endocrinol Lett 2012;33: 207-211.
61. Kattan MW. Judging new markers by their ability to improve predictive accuracy. Journal of the National Cancer Institute 2003; 95: 634-635.
62. Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI. Early prognosis in traumatic brain injury: From prophecies to predictions. Lancet Neurology 2010;9: 543-554.
63. Mushkudiani NA, Hukkelhoven CW, Hernandez AV, Murray GD, Choi SC, Maas AI, Steyerberg EW. A systematic review finds methodological improvements necessary for prognostic models in determining traumatic brain injury outcomes. Journal of Clinical Epidemiology 2008;61: 331-343.